288 related articles for article (PubMed ID: 15840683)
1. Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients.
Walters BA; Van Wyck DB
Nephrol Dial Transplant; 2005 Jul; 20(7):1438-42. PubMed ID: 15840683
[TBL] [Abstract][Full Text] [Related]
2. [Parenteral iron therapy: problems and possible solutions].
Hoigné R; Breymann C; Künzi UP; Brunner F
Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
[TBL] [Abstract][Full Text] [Related]
3. Fatal anaphylaxis after intravenous iron dextran.
Zipf RE
J Forensic Sci; 1975 Apr; 20(2):326-33. PubMed ID: 1123602
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea.
Kim SH; Lee SH; Lee SM; Kang HR; Park HW; Kim SS; Cho SH; Min KU; Kim YY; Chang YS
Eur J Radiol; 2011 Nov; 80(2):363-7. PubMed ID: 20619990
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions and deaths associated with intravenous iron preparations.
Bailie GR; Clark JA; Lane CE; Lane PL
Nephrol Dial Transplant; 2005 Jul; 20(7):1443-9. PubMed ID: 15855210
[TBL] [Abstract][Full Text] [Related]
6. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
Sav T; Tokgoz B; Sipahioglu MH; Deveci M; Sari I; Oymak O; Utas C
Ren Fail; 2007; 29(4):423-6. PubMed ID: 17497463
[TBL] [Abstract][Full Text] [Related]
7. Intravenous iron dextran for severe refractory restless legs syndrome.
Ondo WG
Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008.
Lin RY; Rodriguez-Baez G; Bhargave GA
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):442-5. PubMed ID: 19927545
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
[TBL] [Abstract][Full Text] [Related]
10. Use of parenteral iron products and serious anaphylactic-type reactions.
Wysowski DK; Swartz L; Borders-Hemphill BV; Goulding MR; Dormitzer C
Am J Hematol; 2010 Sep; 85(9):650-4. PubMed ID: 20661919
[TBL] [Abstract][Full Text] [Related]
11. Is low-molecular weight iron dextran really the most risky iron?--Unconvincing data from an unconvincing study.
DeLoughery TG; Auerbach M
Am J Hematol; 2016 May; 91(5):451-2. PubMed ID: 26873795
[No Abstract] [Full Text] [Related]
12. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Coyne DW; Adkinson NF; Nissenson AR; Fishbane S; Agarwal R; Eschbach JW; Michael B; Folkert V; Batlle D; Trout JR; Dahl N; Myirski P; Strobos J; Warnock DG;
Kidney Int; 2003 Jan; 63(1):217-24. PubMed ID: 12472786
[TBL] [Abstract][Full Text] [Related]
13. Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign.
Uguz A; Lack G; Pumphrey R; Ewan P; Warner J; Dick J; Briggs D; Clarke S; Reading D; Hourihane J
Clin Exp Allergy; 2005 Jun; 35(6):746-50. PubMed ID: 15969665
[TBL] [Abstract][Full Text] [Related]
14. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice.
Ewan PW; Clark AT
Clin Exp Allergy; 2005 Jun; 35(6):751-6. PubMed ID: 15969666
[TBL] [Abstract][Full Text] [Related]
16. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Wang C; Graham DJ; Kane RC; Xie D; Wernecke M; Levenson M; MaCurdy TE; Houstoun M; Ryan Q; Wong S; Mott K; Sheu TC; Limb S; Worrall C; Kelman JA; Reichman ME
JAMA; 2015 Nov; 314(19):2062-8. PubMed ID: 26575062
[TBL] [Abstract][Full Text] [Related]
17. Immunologic studies of anaphylaxis to iron dextran in patients on renal dialysis.
Novey HS; Pahl M; Haydik I; Vaziri ND
Ann Allergy; 1994 Mar; 72(3):224-8. PubMed ID: 7510461
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
19. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
Raut CP; Hunt KK; Akins JS; Daley MD; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
Cancer; 2005 Aug; 104(4):692-9. PubMed ID: 15981283
[TBL] [Abstract][Full Text] [Related]
20. Adverse reactions to total-dose infusion of iron dextran.
Shimada A
Clin Pharm; 1982; 1(3):248-9. PubMed ID: 7185520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
